Oysters could help combat antibiotic resistance
The mollusk shows infection-fighting capabilities
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
The answer to fighting a growing number of superbugs may be in the water. Researchers in Australia have pinpointed a protein found in oysters as a way to make antibiotics more effective. As infections rise and become harder to fight, finding new sources of antimicrobials will be more important than ever.
Breaking bacteria shells
Oysters contain an antimicrobial protein in their liquid that is similar to blood, according to a new study published in the journal PLOS One. This protein, called hemolymph, was found by researchers to be "effective at killing the bacteria Streptococcus pneumoniae, which mainly causes pneumonia, and Streptococcus pyogenes, the culprit for strep throat and scarlet fever," although it has not yet been tested on humans and animals, said The Guardian. The protein was discovered in the Sydney rock oyster (Saccostrea glomerata), native to Australia and New Zealand.
Many bacteria, like S. pneumoniae, are able to evade antibiotics by forming a "biofilm," or a community of "microorganisms that attach themselves to surfaces in a sticky, protective matrix," said Popular Science. Hemolymph was effective at killing the bacteria on its own, and "when paired up with antibiotics, the protein also helped improve their effectiveness against other infection-causing bacteria," said Smithsonian Magazine. Scientists believe the protein is successful because it disrupts the bacteria's biofilm. The protein was also found to be non-toxic to human lung cells.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since the majority of antibiotics used today — as well as those currently in development — come from natural sources, scientists are always on the hunt for new sources. "Most organisms have natural defense mechanisms to protect themselves against infection," Kirsten Benkendorff, a marine scientist at Australia's Southern Cross University and the study coauthor, said in a statement. "Oysters are constantly filtering bacteria from the water, so they are a good place to look for potential antibiotics."
The world is our oyster
Antibiotic resistance has become a growing problem in public health. Bacteria are becoming more resistant due to the high number of infections, especially of the respiratory tract, and the overuse of antibiotics to treat them. This has led the microorganisms to evolve into stronger superbugs. Coupled with the ability to form a biofilm, infections are becoming much harder to kill. A 2024 study predicted that by 2050, approximately 2 million people, mostly 70 and over, could die from drug-resistant infections each year. "Because of this, new antibiotic treatments that can inhibit, disrupt or penetrate biofilms are very valuable," said Benkendorff and Kate Summer, another coauthor of the PLOS One study, at The Conversation.
While hemolymph shows promise, "more work is needed, including testing in animals and clinical human trials," said Benkendorff and Summer. "Sustainable supply of the proteins for research and medical use is an important consideration, but this is helped by the fact [that] Sydney rock oysters are commercially available." This research also presents an opportunity for collaboration between the pharmaceutical and aquaculture industries. "Given the significant costs in developing new medicines, the idea of using excess and/or imperfect oysters to generate a sustainable supply of antimicrobial proteins" should be "investigated further," Branwen Morgan, a researcher at Australia's Commonwealth Scientific and Industrial Research Organization, said to The Guardian.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Switzerland could vote to cap its populationUnder the Radar Swiss People’s Party proposes referendum on radical anti-immigration measure to limit residents to 10 million
-
Political cartoons for February 15Cartoons Sunday's political cartoons include political ventriloquism, Europe in the middle, and more
-
The broken water companies failing England and WalesExplainer With rising bills, deteriorating river health and a lack of investment, regulators face an uphill battle to stabilise the industry
-
Scientists are worried about amoebasUnder the radar Small and very mighty
-
Growing a brain in the labFeature It's a tiny version of a developing human cerebral cortex
-
Metal-based compounds may be the future of antibioticsUnder the radar Robots can help develop them
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Mixed nuts: RFK Jr.’s new nutrition guidelines receive uneven reviewsTalking Points The guidelines emphasize red meat and full-fat dairy
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
The truth about vitamin supplementsThe Explainer UK industry worth £559 million but scientific evidence of health benefits is ‘complicated’
-
Deaths of children under 5 have gone up for the first time this centuryUnder the radar Poor funding is the culprit
